Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Mexico for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Mexico only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Mexico (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Kamalesh Ramaiya (NPI 1467568485)

Field	Value
Entity Type	Individual
Organization	Kamalesh Ramaiya
Address	5757 Harper Dr Ne
City	Albuquerque
State	NM
ZIP	87109
Taxonomy	Ophthalmology Physician
NPI Enumerated	August 22, 2006

Payer Source	Total Paid
Medicare	$2.9M
Medicaid	$0

Key Findings

This provider is effectively single‑payer: Total Medicare revenue: $2.9M while Total Medicaid revenue: none (no Medicaid billing on file). All reported billing activity is Medicare-based, so payer mix risk and contracting exposure are concentrated entirely in the Medicare program rather than split across Medicare and Medicaid. This suggests any payer negotiations or utilization reviews would be Medicare-focused.

Revenue concentration is extremely high: the precomputed top 3 Medicare codes by revenue account for 85.9% of this provider's total Medicare revenue. The single largest line item is J0178 with $1.8M revenue (62.6% of Medicare revenue), followed by J2777 at $502.9K (17.4%) and 67028 at $168.5K (5.8%), indicating the practice’s economics are driven almost entirely by a very small set of services.

The service mix and code descriptions identify a retina/intravitreal injection–focused ophthalmology practice: major revenue drivers are J0178 (aflibercept) and J2777 (faricimab) along with 67028 (intravitreal injection as an isolated procedure). Frequent use of these medication-injection codes combined with retinal imaging (see 92134) and E&M codes is consistent with routine, longitudinal injection clinics managing macular degeneration and related retinal disease.

Competitive standing on top injectable codes is modest-to-strong but described as typical in national context: J0178 (2.6K claims, $688 avg paid/claim, $1.8M revenue) ranks #272 of 3204 nationally (92th percentile; typical, unremarkable volume for this code), J2777 (17.3K claims, $29 avg paid/claim, $502.9K revenue) ranks #619 of 2039 (70th percentile; typical, unremarkable volume for this code), and 67028 (1.9K claims, $89 avg paid/claim, $168.5K revenue) ranks #462 of 4255 (89th percentile; typical, unremarkable volume for this code). These placements indicate steady, above‑median activity on retina injections but not dominance relative to national peers.

Utilization of office E&M and retinal imaging is a notable operational signal: 99214 appears with 868 claims and $69.4K revenue and ranks #16174 of 479517 providers nationally (97th percentile; notably above typical national volume for this code), and 92134 has 1.4K claims and $36.6K revenue and ranks #1633 of 26868 providers nationally (94th percentile; notably above typical national volume for this code). This combination implies substantial follow-up visit and OCT/retinal imaging throughput to support frequent injection therapy, creating predictable clinic visit flows and ancillary service demand.

There are some low-visibility or infrequently used billing lines: J3590 (Unclassified biologics) accounts for $55.1K (1.9% of Medicare revenue) but ranks #545 of 631 (13th percentile; typical, unremarkable volume for this code), and J2778 (ranibizumab) contributes $114K (4.0%) and sits at the 49th percentile. Those placements indicate occasional use of alternative biologics or unclassified biologic billing but not at levels that distinguish the provider from peers.

The presence of surgical retina codes shows episodic tertiary care capacity: 67113 (15 claims, $14.9K revenue) and 67042 (11 claims, $9.1K revenue) appear on the file, indicating the provider performs complex retinal repair and vitrectomy procedures at low volume relative to its injection clinic work. These procedure codes, while small contributors to revenue, suggest capability to escalate care from injections and imaging to surgical intervention when clinically required.

Tenure and provider experience: NPI enumerated on 2006-08-22 (~20 years ago), indicating long-standing Medicare participation. This multi-decade enumeration combined with concentrated, routine injection throughput and above‑median imaging/E&M volumes is consistent with an established retina-focused ophthalmology practice with stable referral and follow-up patterns in the Medicare population.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

20 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,630	$690	$1.8M
J2777	Injection, faricimab‑svoa, 0.1 mg	17,340	$30	$502.9K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,890	$90	$168.5K
J2778	Injection, ranibizumab, 0.1 mg	630	$180	$114K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	870	$80	$69.4K
J3590	Unclassified biologics	30	$2,210	$55.1K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,410	$30	$36.6K
J7999	Compounded drug, not otherwise classified	590	$60	$36.5K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	220	$150	$32.1K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	320	$60	$19.8K

Showing 1–10 of 20

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 20 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Mexico Distribution

Kamalesh Ramaiya — 4 of 20 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Mexico

Full comparison — all codes billed, vs. state median

20 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	2	20	1,100	$690	$816.1K
J2777	8	20	17,340	$30	$653.4K
J2778	7	10	720	$180	$247.3K
J3590	4	10	30	$1,420	$97.9K
67028	5	30	390	$90	$71.6K
J7312	6	10	310	$150	$50.2K
67042	8	10	30	$980	$31.3K
J7999	1	10	320	$60	$18.6K
92014	140	180	130	$70	$18.5K
67113	3	10	20	$900	$14.4K

Showing 1–10 of 20

Related Providers

Other providers that share a Tax Identification Number (TIN) with Kamalesh Ramaiya, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Eye Associates Of New Mexico Ltd	NM	Ophthalmology Physician	$0	$46.9M
John Pitcher	NM	Ophthalmology Physician	$5.1M	$0
Mark Chiu	NM	Ophthalmology Physician	$3.8M	$0
Christopher Roybal	NM	Ophthalmology Physician	$3.8M	$0
Ashok Reddy	NM	Ophthalmology Physician	$3.2M	$0
Betty Klein	NM	Ophthalmology Physician	$2.4M	$0
Rizwan Shaikh	LA	Ophthalmology Physician	$2.2M	$0
Iuri Golubev	NM	Ophthalmology Physician	$1.7M	$0
Eye Associates Of New Mexico, Ltd.	NM	Durable Medical Equipment & Medical Supplies	$0	$1.6M
Ian Thompson	NM	Ophthalmology Physician	$1.3M	$0

Nearby Providers

Other providers in the same ZIP code as Kamalesh Ramaiya, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Presbyterian Healthcare Services	NM	Internal Medicine Physician	$0	$240.8M
Heritage Home Healthcare Services, Inc.	NM	Home Health Agency	$0	$141.5M
Home Medical Equipment Specialists LLC	NM	Durable Medical Equipment & Medical Supplies	$0	$100M
The New Beginnings LLC	NM	Adult Day Care Clinic/Center	$0	$85.1M
We Care Agency, Inc.	NM	In Home Supportive Care Agency	$0	$60.1M
Lovelace Health System, LLC	NM	General Acute Care Hospital	$0	$57.7M
Adelante Development Center, Inc.	NM	Personal Care Attendant	$0	$57M
Southwest Labs LLC	NM	Clinical Medical Laboratory	$1.1M	$41.5M
Southwest Medical Associates, LLC	NM	General Practice Physician	$0	$41.4M
Tspc-nm, LLC	NM	Nursing Care Agency	$0	$28.9M

Kamalesh Ramaiya — Billing Profile & Reimbursement Data

Sign up for Kamalesh Ramaiya — Billing Profile & Reimbursement Data policy alerts

Kamalesh Ramaiya — Billing Profile & Reimbursement Data

Sign up for Kamalesh Ramaiya — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References